Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
LBPHDelisted Stock | USD 59.98 0.00 0.00% |
Under 52% of Longboard Pharmaceuticals' traders are presently thinking to get in. The analysis of overall sentiment of trading Longboard Pharmaceuticals stock suggests that some investors are interested at this time. Longboard Pharmaceuticals' investing sentiment shows overall attitude of investors towards Longboard Pharmaceuticals.
Longboard |
Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for n
Read at businesswire.com
Longboard Pharmaceuticals Fundamental Analysis
We analyze Longboard Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Longboard Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Longboard Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Longboard Pharmaceuticals is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Longboard Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Longboard Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Longboard Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Longboard Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Longboard Pharmaceuticals Related Equities
GLUE | Monte Rosa | 6.45 | ||||
SNSE | Sensei Biotherapeutics | 4.65 | ||||
DSGN | Design Therapeutics | 4.34 | ||||
CELC | Celcuity LLC | 3.83 | ||||
STOK | Stoke Therapeutics | 3.36 | ||||
TIL | Instil Bio | 2.64 | ||||
CCCC | C4 Therapeutics | 2.60 | ||||
NXTC | NextCure | 2.11 | ||||
HOWL | Werewolf Therapeutics | 1.27 | ||||
MNOV | MediciNova | 0.46 | ||||
EWTX | Edgewise Therapeutics | 0.06 | ||||
NUVB | Nuvation Bio | 0.37 | ||||
CSBR | Champions Oncology | 0.53 | ||||
MOLN | Molecular Partners | 2.68 | ||||
IKNA | Ikena Oncology | 3.73 | ||||
ASMB | Assembly Biosciences | 3.80 | ||||
ANEB | Anebulo Pharmaceuticals | 10.81 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Longboard Stock
If you are still planning to invest in Longboard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Longboard Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |